Characteristic | Mean (or Median) or Percentage |
---|---|
Gender, male rate | 40% |
Age, years | 12.91 (SD 2.37) |
BMI, kg/m2 | 20.23 (SD 3.87) |
JIA subtype | |
Oligoarticular | 75% |
Polyarticular | 16% |
Undifferentiated | 9% |
Pharmacological treatment | |
Follow-up without medication | 19% |
NSAID only | 19% |
DMARD (with or without NSAID) | 62% |
Disease duration, months | 41.00 (SD 38.05) |
DAS28 | 2.85 (SD 1.23) |
Hip arthritis | 12.5% |
Knee arthritis | 28.1% |
Foot/ankle arthritis | 15.6% |
JADI-A | 0 (IQR 1) (min 0, max 8) |
LED positivity rate | 37.5% |
6MWT, m (n: 30) | 427.76 (SD 107.47) |
CYC-E test duration, min | 10.46 (SD 4.22) |
CHAQ | 0.13 (IQR 0, 0.69) |
PedsQL-3A | 84.37 (SD 13.45) |